An Open Bazaar for Drug Development: Molecule Protocol
<p><strong><em>Imagine a world where patients directly fund researchers developing the next therapeutic breakthrough they need. One where drug development is collaborative, open, and decentralized — an </em></strong><a href="https://en.wikipedia.org/wiki/The_Cathedral_and_the_Bazaar" rel="noopener ugc nofollow" target="_blank"><strong><em>open bazaar</em></strong></a><strong><em> anyone with the right intentions can join. A system that could radically increase the diversity of treatments, and lower costs and time to market.</em></strong></p>
<p>The majority of promising early-stage therapeutic research lacks funding and access. Funders struggle to discover and engage with suitable projects. In addition, IP is a highly illiquid, bureaucratic and opaque asset class that restricts virtual scientific collaboration through printed and filed legal constraints.</p>
<p><a href="https://medium.com/molecule-blog/an-open-bazaar-for-drug-development-molecule-protocol-a47978dd914"><strong>Click Here</strong></a></p>